ARCHIVES

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

This article is from The Cancer Letter archive.

Vol. 03 No. 15 | April 15, 1977

Download PDF Visit The Full Archive

Related Articles

Fisher Says Forget Grants-Contract Argument; What’s Needed Is More Flexibility

April 13, 1979

In Brief: Tipping Resigns Forom ACS; Vaughan Joins UAB BMT Program; PCI Recruits Ball, Finn, Mirro

September 20, 1991

ASCO Lists Top 11 Advances In Clinical Cancer Research

December 30, 2005

NCAB Recommends Withdrawal Of CRCC Comprehensive Status

February 13, 1981

Pancreatic Cancer Pain Reduction Concept Approved

May 23, 1986

Dingell: “Unable To Vouch” For Staff Report On NCI’s Gallo

February 10, 1995